186 related articles for article (PubMed ID: 28247741)
21. Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study).
Kawai T; Matsuyama H; Kobayashi K; Ikeda A; Miyake M; Nishimoto K; Matsushita Y; Nishiyama H; Fujimoto K; Oyama M; Miyake H; Azuma H; Inoue K; Mitsui T; Kawakita M; Oyama C; Mizokami A; Abe T; Kuroiwa H; Kume H
Int J Urol; 2024 May; ():. PubMed ID: 38695571
[TBL] [Abstract][Full Text] [Related]
22. Identification of risk factors associated with oral 5-aminolevulinic acid-induced hypotension in photodynamic diagnosis for non-muscle invasive bladder cancer: a multicenter retrospective study.
Fukuhara H; Nohara T; Nishimoto K; Hatakeyama Y; Hyodo Y; Okuhara Y; Oyama M; Mizokami A; Inoue K; Matsuyama H;
BMC Cancer; 2021 Nov; 21(1):1223. PubMed ID: 34774000
[TBL] [Abstract][Full Text] [Related]
23. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT.
Fukuhara H; Yamamoto S; Lai HW; Karashima T; Kurabayashi A; Furihata M; Inoue K
Photodiagnosis Photodyn Ther; 2022 Jun; 38():102757. PubMed ID: 35151889
[TBL] [Abstract][Full Text] [Related]
24. Repeat Transurethral Resection for Non-muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era.
Yanagisawa T; Kawada T; von Deimling M; Bekku K; Laukhtina E; Rajwa P; Chlosta M; Pradere B; D'Andrea D; Moschini M; Karakiewicz PI; Teoh JY; Miki J; Kimura T; Shariat SF
Eur Urol Focus; 2024 Jan; 10(1):41-56. PubMed ID: 37495458
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance of image technique based transurethral resection for non-muscle invasive bladder cancer: systematic review and diagnostic meta-analysis.
Chen C; Huang H; Zhao Y; Liu H; Sylvester R; Lin T; Huang J
BMJ Open; 2019 Oct; 9(10):e028173. PubMed ID: 31628123
[TBL] [Abstract][Full Text] [Related]
26. [Is a routine second transurethral resection of the bladder still necessary after hexaminolévulinate photodynamic diagnosis-assisted TURBT?].
Doisy L; Walz J; Fakhfakh S; Rybikowski S; Koskas Y; Gravis G; Pignot G
Prog Urol; 2019; 29(6):332-339. PubMed ID: 31104952
[TBL] [Abstract][Full Text] [Related]
27. The Japanese health care system-based cost-effectiveness of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer.
Nishimura N; Miyake M; Miyamoto T; Tomizawa M; Shimizu T; Morizawa Y; Hori S; Gotoh D; Nakai Y; Torimoto K; Tanaka N; Fujimoto K
Jpn J Clin Oncol; 2023 Mar; 53(4):343-348. PubMed ID: 36585780
[TBL] [Abstract][Full Text] [Related]
28. Does the quality of endoscopic equipment influence the recurrence rate after photodynamic diagnosis-assisted transurethral resection of bladder tumor?
Nakagawa R; Nohara T; Kano H; Makino T; Naito R; Iwamoto H; Yaegashi H; Kawaguchi S; Shigehara K; Izumi K; Mizokami A
Photodiagnosis Photodyn Ther; 2024 Apr; 46():104023. PubMed ID: 38401816
[TBL] [Abstract][Full Text] [Related]
29. Bladder cancer prospective cohort study on high-risk non-muscle invasive bladder cancer after photodynamic diagnosis-assisted transurethral resection of the bladder tumor (BRIGHT study).
Kobayashi K; Matsuyama H; Kawai T; Ikeda A; Miyake M; Nishimoto K; Matsushita Y; Komura K; Abe T; Kume H; Nishiyama H; Fujimoto K; Oyama M; Miyake H; Inoue K; Mitsui T; Kawakita M; Ohyama C; Mizokami A; Kuroiwa H
Int J Urol; 2022 Jul; 29(7):632-638. PubMed ID: 35293022
[TBL] [Abstract][Full Text] [Related]
30. [Initial Experience of Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumor (PDD-TURBT)].
Sugino Y; Nishikawa K; Kato M; Sasaki T; Kato M; Masui S; Yoshio Y; Kanda H; Sugimura Y; Inoue T
Hinyokika Kiyo; 2021 Jul; 67(7):303-308. PubMed ID: 34353010
[TBL] [Abstract][Full Text] [Related]
31. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer: a study protocol for a randomised trial of clinical and cost-effectiveness.
Tandogdu Z; Lewis R; Duncan A; Penegar S; McDonald A; Vale L; Shen J; Kelly JD; Pickard R; N Dow J; Ramsay C; Mostafid H; Mariappan P; Nabi G; Creswell J; Lazarowicz H; McGrath J; Taylor E; Clark E; Maclennan G; Norrie J; Hall E; Heer R;
BMJ Open; 2019 Sep; 9(9):e022268. PubMed ID: 31481549
[TBL] [Abstract][Full Text] [Related]
33. Time to Turn on the Blue Lights: A Systematic Review and Meta-analysis of Photodynamic Diagnosis for Bladder Cancer.
Veeratterapillay R; Gravestock P; Nambiar A; Gupta A; Aboumarzouk O; Rai B; Vale L; Heer R
Eur Urol Open Sci; 2021 Sep; 31():17-27. PubMed ID: 34467237
[TBL] [Abstract][Full Text] [Related]
34. A network meta-analysis of therapeutic outcomes after new image technology-assisted transurethral resection for non-muscle invasive bladder cancer: 5-aminolaevulinic acid fluorescence vs hexylaminolevulinate fluorescence vs narrow band imaging.
Lee JY; Cho KS; Kang DH; Jung HD; Kwon JK; Oh CK; Ham WS; Choi YD
BMC Cancer; 2015 Aug; 15():566. PubMed ID: 26232037
[TBL] [Abstract][Full Text] [Related]
35. Blue vs white light for transurethral resection of non-muscle-invasive bladder cancer: an abridged Cochrane Review.
Maisch P; Koziarz A; Vajgrt J; Narayan V; Kim MH; Dahm P
BJU Int; 2022 Dec; 130(6):730-740. PubMed ID: 35238145
[TBL] [Abstract][Full Text] [Related]
36. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results.
Naito S; Algaba F; Babjuk M; Bryan RT; Sun YH; Valiquette L; de la Rosette J;
Eur Urol; 2016 Sep; 70(3):506-15. PubMed ID: 27117749
[TBL] [Abstract][Full Text] [Related]
37. Comparison of hexaminolevulinate (HAL) -guided versus white light transurethral resection for NMIBC: A systematic review and meta-analysis of randomized controlled trials.
Zhao H; Peng P; Luo Z; Liu H; Sun J; Wang X; Jia Q; Yang Z
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103220. PubMed ID: 36462704
[TBL] [Abstract][Full Text] [Related]
38. [Cost-effectiveness of transurethral resection of the bladder with blue light in patients with non muscle invasive bladder cancer in France].
Rouprêt M; Malavaud B; Molinier L; Leleu H; Blachier M; Marteau F
Prog Urol; 2015 Apr; 25(5):256-64. PubMed ID: 25605343
[TBL] [Abstract][Full Text] [Related]
39. Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors.
Burger M; Stief CG; Zaak D; Stenzl A; Wieland WF; Jocham D; Otto W; Denzinger S
Urology; 2009 Dec; 74(6):1282-6. PubMed ID: 19819538
[TBL] [Abstract][Full Text] [Related]
40. Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer.
Rolevich AI; Zhegalik AG; Mokhort AA; Minich AA; Vasilevich VY; Polyakov SL; Krasny SA; Sukonko OG
World J Urol; 2017 May; 35(5):745-752. PubMed ID: 27604374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
